samedan logo
 
 
 
spacer
home > ebr > spring 2004 > new trends in dermatology clinical research
PUBLICATIONS
European Biopharmaceutical Review

New Trends in Dermatology Clinical Research

In dermatology it is often possible to establish clinical efficacy before committing to a full clinical and safety programme. This is because the focus of dermatology - the skin - is directly accessible for therapy. In contrast to systemic or topical application to large areas, in many cases a very small treatment area can be selected for dosing of topical therapies, effectively eliminating risks associated with systemic exposure.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Betsy Hughes-Formella, Managing Director at Bioskin GmbH

Dr Betsy Hughes-Formella received her PhD in Physiology from the University of Georgia in Athens, Georgia in 1983. She moved to Germany to join a research team at the University Medical Center in Hamburg. Her research interests were in the area of steroid receptors in the neuromuscular system and later in the pathogenesis of melanoma. In 1992 Dr Hughes joined Bioskin GmbH as Managing Director. In her current capacity she consultants and advises on clinical development concepts and study designs for Bioskin sponsors. In addition, she is responsible for the co-ordination of the company's business development and strategic alliance opportunities. She is an active member of several scientific societies, including a position on the board of regents of the German Association of Applied Human Pharmacology (AGAH) and the working group for dermocosmetics in the German Association for Dermopharmacie (GD).

spacer
Dr Betsy Hughes-Formella
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Turkish Cargo keeps growing in the first quarter of 2019

Maintaining its accomplished operations from Ataturk and Istanbul airports as "Dual Hub", the global brand of Turkish Cargo continued its strong growth momentum during the first quarter of the year despite the shrinkage of the global air cargo sector.
More info >>

White Papers

Choosing the Right CMO for HPAPI Manufacturing

AMRI

Over the past few years a steady stream of contract manufacturing organizations (CMO) have added high potency active pharmaceutical ingredient (HPAPI) production capacity. The expansions give biopharma executives charged with selecting HPAPI production partners an unprecedented number of options, but all this choice creates a problem which CMO should you pick when each is touting similar technical capabilities?
More info >>

 
Industry Events

12th World Meeting on Pharmaceutics, Biopharmaceutics and Pharmaceutical Technology

8-11 February 2021, Vienna, Austria

In continuation of the very successful scientific meetings in Budapest, Paris, Berlin, Florence, Geneva, Barcelona, Malta, Istanbul, Lisbon, Glasgow and Granada, the 12th PBP World will be held in Vienna from 8-11 Feb 2021. This every two year held conference has gained an ever increasing impact among the pharmaceutical scientists: With up to 1000 submitted abstracts and about 1300 participants it has become a well-established major meeting, attracting scientists from all over the world.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement